肝脏表面结节性评分可预测肝硬化失代偿和死亡
本研究为回顾性研究,纳入830例肝硬化患者,利用常规CT图像测量肝脏表面结节性(LSN)评分,发现LSN评分可独立预测肝硬化失代偿和死亡,且结合MELD评分构建的风险模型能区分不同风险的患者。
要点
- LSN评分从常规CT图像获得,可独立预测肝硬化失代偿和死亡。
- LSN评分≥3且MELD评分≥10的高风险患者预后较差。
- LSN评分联合MELD评分可用于风险分层。
核心结论
- 从常规CT图像获得的LSN评分可预测肝硬化失代偿和死亡。
研究设计与样本
- 回顾性研究,纳入830例肝硬化患者,LSN评分通过CT图像和定量软件测量,采用竞争风险回归分析。
诊断标准与关键数值
- LSN评分对肝失代偿的调整风险比HR 1.38(95%CI 1.06-1.79)。
- LSN评分对死亡的调整风险比HR 1.22(95%CI 1.11-1.33)。
- MELD评分对死亡的调整风险比HR 1.08(95%CI 1.06-1.11)。
临床应用与阅片要点
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Purpose To determine whether use of the liver surface nodularity (LSN) score, a quantitative biomarker derived from routine computed tomographic (CT) images, allows prediction of cirrhosis decompensation and death. Materials and Methods For this institutional review board-approved HIPAA-compliant retrospective study, adult patients with cirrhosis and Model for End-Stage Liver Disease (MELD) score within 3 months of initial liver CT imaging between January 3, 2006, and May 30, 2012, were identified from electronic medical records (n = 830). The LSN score was measured by using CT images and quantitative software. Competing risk regression was used to determine the association of the LSN score with hepatic decompensation and overall survival. A risk model combining LSN scores (<3 or ≥3) and MELD scores (<10 or ≥10) was created for predicting liver-related events. Results In patients with compensated cirrhosis, 40% (129 of 326) experienced decompensation during a median follow-up period of 4.22 years. After adjustment for competing risks including MELD score, LSN score (hazard ratio, 1.38; 95% confidence interval: 1.06, 1.79) was found to be independently predictive of hepatic decompensation. Median times to decompensation of patients at high (1.76 years, n = 48), intermediate (3.79 years, n = 126), and low (6.14 years, n = 152) risk of hepatic decompensation were significantly different (P < .001). Among the full cohort with compensated or decompensated cirrhosis, 61% (504 of 830) died during the median follow-up period of 2.26 years. After adjustment for competing risks, LSN score (hazard ratio, 1.22; 95% confidence interval: 1.11, 1.33) and MELD score (hazard ratio, 1.08; 95% confidence interval: 1.06, 1.11) were found to be independent predictors of death. Median times to death of patients at high (0.94 years, n = 315), intermediate (2.79 years, n = 312), and low (4.69 years, n = 203) risk were significantly different (P < .001). Conclusion The LSN score derived from routine CT images allows prediction of cirrhosis decompensation and death. ©RSNA, 2016 Online supplemental material is available for this article.
引用
- Smith AD, Zand KA, Florez E, et al. Liver Surface Nodularity Score Allows Prediction of Cirrhosis Decompensation and Death. Radiology. 2016. PMID: 27809664. doi:10.1148/radiol.2016160799
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。